Can You Receive Dialysis on Palliative Care?

End-Stage Renal Disease (ESRD) describes the final stage of chronic kidney failure, where the kidneys are no longer able to function on their own. Life-sustaining treatments like dialysis or a kidney transplant become necessary to filter wastes and excess fluid from the blood. Patients often wonder if they must choose between aggressive treatment and comfort-focused care. The answer is that you can receive dialysis on palliative care. Palliative care is specialized medical support that focuses on relieving suffering and improving quality of life at any stage of a serious illness. This care is distinct from hospice, which is generally reserved for the final six months of life when curative treatments have stopped.

Integrating Dialysis and Palliative Care

Palliative care serves as an extra layer of support that works in parallel with life-prolonging therapies such as hemodialysis or peritoneal dialysis. The goal is to manage the complex symptoms and emotional burdens of advanced kidney disease that dialysis alone cannot fully resolve. This integrated approach ensures patients benefit from the life-extending aspects of dialysis while receiving focused attention on their overall well-being.

The care is delivered by a multidisciplinary team that works alongside the nephrology team responsible for the dialysis treatment plan. This team typically includes palliative care physicians, nurses, social workers, and chaplains. They focus on identifying and treating symptoms common with ESRD, such as persistent pain, debilitating fatigue, sleep disturbances, and severe pruritus.

The palliative care team also provides psychological and spiritual support for patients and their families as they navigate the emotional toll of living with a serious illness. By addressing issues such as anxiety, depression, and treatment-related distress, they help maintain the patient’s quality of life throughout treatment. This partnership ensures the patient’s personal values and comfort are prioritized while they continue dialysis.

Shared Decision-Making in ESRD Treatment Planning

The integration of palliative care often leads to detailed goals-of-care conversations between the patient, their family, and the medical team. These discussions move beyond simply choosing a treatment and center on aligning medical interventions with the patient’s personal values and priorities. Patients with ESRD face high rates of morbidity and mortality, which makes understanding the realistic prognosis a crucial part of this planning.

During these conversations, prognostic data are discussed to provide a realistic picture of the future. Tools like the “best-/worst-case framework” help illustrate the potential burdens and benefits of continuing dialysis versus pursuing Conservative Kidney Management (CKM), which focuses solely on symptom control. This process ensures the patient’s autonomy is respected by evaluating how well each path aligns with what makes their life meaningful.

A core component of this shared decision-making is establishing or reviewing the patient’s advance directives. This includes designating a healthcare proxy, a trusted person to make medical decisions if the patient becomes unable to communicate their wishes. Documenting these preferences ensures that the patient’s goals for quality of life and comfort will guide their care, even if their condition rapidly declines. These discussions are an ongoing process, evolving as the patient’s health status and priorities change over time.

Withdrawing Dialysis: The Comfort Care Pathway

When the burdens of dialysis begin to outweigh the benefits, a patient may choose Dialysis Withdrawal of Treatment (DWOT), a planned decision to shift focus entirely to comfort. This process respects the patient’s right to refuse any life-sustaining treatment, which is protected by law, and is distinctly different from euthanasia or physician-assisted suicide. The decision marks a transition to full comfort care, often in the form of hospice services, ensuring the patient is not abandoned by their medical team.

Once the decision is made, the medical team initiates a systematic plan that includes discontinuing all treatments that no longer serve the goal of comfort. This involves stopping unnecessary medications and tests, and formally clarifying the patient’s resuscitation status. The palliative care team ensures that the transition is smooth, providing continuous emotional and spiritual support to the patient and their family.

The expected timeline after discontinuing dialysis varies significantly. For patients who have minimal to no residual urine output, the mean survival is typically around 8 to 10 days. However, patients with some remaining kidney function may live for several weeks. Throughout this period, the focus is entirely on aggressive symptom management to ensure a peaceful and dignified final stage of life.

Specialized Symptom Control for Advanced Kidney Disease

Following the withdrawal of dialysis, the palliative care team manages the rapid accumulation of waste products and fluid that would normally be removed by the machine. The goal is not to reverse the physiological changes but to ensure that the resulting symptoms do not cause distress. Fluid overload, which can lead to shortness of breath (dyspnea) and swelling, is primarily managed with positioning, oxygen, and targeted medications.

Specialized symptom management is required because many standard medications are normally cleared by the kidneys and can quickly build up to toxic levels. For pain and dyspnea, opioids like fentanyl, methadone, or buprenorphine are preferred because their metabolites are safer in the setting of kidney failure compared to common opioids like morphine. Intravenous fluids are generally avoided as they can worsen edema and fluid congestion in the lungs, increasing discomfort.

Neurological symptoms, such as confusion, agitation, and muscle twitching (myoclonus), are also common due to the buildup of uremic toxins. These are treated with careful, low-dose use of medications such as benzodiazepines, like clonazepam, to ensure comfort without excessive sedation. This careful, non-dialytic management of symptoms is essential to maintain the patient’s comfort in the final days and weeks.